Clovis Oncology to Present at the 9th Annual SVB Leerink Healthcare Conference
February 11 2020 - 4:05PM
Business Wire
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its
Chief Executive Officer and President, Patrick J. Mahaffy, will
present at the 9th Annual SVB Leerink Global Healthcare Conference
on Wednesday, February 26, 2020 at 10:30 a.m. Eastern Standard
Time. The conference will be held at the Lotte New York Palace in
New York City.
A live webcast of the presentation and Q&A session can be
accessed through the investor relations section of the Company’s
website at www.clovisoncology.com. Following the live presentation,
a replay of the webcast will be available on the Company’s website
for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer
agents in the U.S., Europe and additional international markets.
Clovis Oncology targets development programs at specific subsets of
cancer populations, and simultaneously develops, with partners,
diagnostic tools intended to direct a compound in development to
the population that is most likely to benefit from its use. Clovis
Oncology is headquartered in Boulder, Colorado; please visit
www.clovisoncology.com for more information, including additional
office locations in the U.S. and Europe.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200211005667/en/
Anna Sussman 303.625.5022 asussman@clovisoncology.com Breanna
Burkart 303.625.5023 bburkart@clovisoncology.com
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Apr 2023 to Apr 2024